John C. McLenithan

5.0k total citations · 3 hit papers
39 papers, 3.6k citations indexed

About

John C. McLenithan is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, John C. McLenithan has authored 39 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Physiology and 11 papers in Surgery. Recurrent topics in John C. McLenithan's work include Adipose Tissue and Metabolism (16 papers), Metabolism, Diabetes, and Cancer (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). John C. McLenithan is often cited by papers focused on Adipose Tissue and Metabolism (16 papers), Metabolism, Diabetes, and Cancer (9 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). John C. McLenithan collaborates with scholars based in United States, Germany and China. John C. McLenithan's co-authors include Alan R. Shuldiner, Susan K. Fried, M. Daniel Lane, Mi‐Jeong Lee, Da‐Wei Gong, Toni I. Pollin, Rongze Yang, Hong Hu, Barbara C. Hansen and Haibin Wu and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

John C. McLenithan

39 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

2006 715 citations Rongze Yang, Alan R. Shuldiner et al. profile →
Omentin Plasma Levels and Gene Expression Are Decreased in Obesity

2007 617 citations Susan K. Fried, Alan R. Shuldiner et al. Diabetes profile →
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

2008 517 citations Toni I. Pollin, Coleen Damcott et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. McLenithan United States	23	1.4k	1.4k	1.3k	830	693	39	3.6k
Robert E. McGehee United States	27	1.3k 1.0×	1.6k 1.2×	1.5k 1.2×	387 0.5×	607 0.9×	48	3.6k
Stéphane Gesta United States	23	1.9k 1.4×	1.6k 1.2×	2.7k 2.2×	1000 1.2×	866 1.2×	50	5.3k
Danièle Daviaud France	31	764 0.6×	1.4k 1.0×	1.1k 0.9×	841 1.0×	1.3k 1.8×	55	4.8k
Hidehiko Kondo Japan	21	2.3k 1.7×	1.2k 0.9×	1.9k 1.5×	702 0.8×	417 0.6×	28	4.4k
Takashi Kadowaki Japan	18	2.0k 1.4×	1.9k 1.4×	1.7k 1.4×	603 0.7×	486 0.7×	31	4.5k
Katherine Cianflone Canada	35	1.2k 0.8×	946 0.7×	1.5k 1.2×	435 0.5×	657 0.9×	91	3.9k
Cristiana E. Juge-Aubry Switzerland	22	1.2k 0.9×	1.1k 0.8×	1.1k 0.9×	492 0.6×	350 0.5×	29	2.9k
Suleiman W. Bahouth United States	34	1.6k 1.2×	1.4k 1.1×	1.6k 1.3×	1.3k 1.6×	715 1.0×	81	4.3k
Philip L.S.M. Gordts United States	25	887 0.6×	877 0.6×	1.6k 1.3×	919 1.1×	802 1.2×	57	3.5k
Pascal Peraldi France	28	1.9k 1.3×	2.8k 2.1×	1.8k 1.4×	450 0.5×	584 0.8×	51	5.8k

Countries citing papers authored by John C. McLenithan

Since Specialization

Citations

This map shows the geographic impact of John C. McLenithan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. McLenithan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. McLenithan more than expected).

Fields of papers citing papers by John C. McLenithan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. McLenithan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. McLenithan. The network helps show where John C. McLenithan may publish in the future.

Co-authorship network of co-authors of John C. McLenithan

This figure shows the co-authorship network connecting the top 25 collaborators of John C. McLenithan. A scholar is included among the top collaborators of John C. McLenithan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. McLenithan. John C. McLenithan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hankey, Kim G., Tim Luetkens, John C. McLenithan, et al.. (2021). Eight-Day Point of Care CAR T-Cell Manufacturing on Clinimacs Prodigy from Healthy Donors As a Proof-of-Concept Study. Blood. 138(Supplement 1). 2851–2851. 1 indexed citations

O’Neill, Andrea, Weiliang Huang, Joaquin M. Muriel, et al.. (2021). μ-Crystallin in Mouse Skeletal Muscle Promotes a Shift from Glycolytic toward Oxidative Metabolism. SHILAP Revista de lepidopterología. 4. 47–59. 2 indexed citations

Zhang, Yaqin, Li Liu, Kseniya Golovnina, et al.. (2016). A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics. EBioMedicine. 8. 49–59. 11 indexed citations

Goloubeva, Olga, et al.. (2015). A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors. Endocrine Related Cancer. 22(4). 645–656. 14 indexed citations

Yerges‐Armstrong, Laura M., Richard B. Horenstein, Toni I. Pollin, et al.. (2014). Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes. New England Journal of Medicine. 370(24). 2307–2315. 151 indexed citations

Cooper, Brandon, John C. McLenithan, Jack L. Arbiser, et al.. (2014). Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells. Microvascular Research. 97. 55–64. 19 indexed citations

Ryan, A. S., Leslie I. Katzel, Steven J. Prior, et al.. (2013). Aerobic Exercise Plus Weight Loss Improves Insulin Sensitivity and Increases Skeletal Muscle Glycogen Synthase Activity in Older Men. The Journals of Gerontology Series A. 69(7). 790–798. 18 indexed citations

Post, Wendy S., John C. McLenithan, Michael L. Terrin, et al.. (2013). Determinants of intrathoracic adipose tissue volume and associations with cardiovascular disease risk factors in Amish. Nutrition Metabolism and Cardiovascular Diseases. 24(3). 286–293. 4 indexed citations

Bhalla, Kavita, Bor Jang Hwang, Jang Hyun Choi, et al.. (2011). N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in Vivo. Journal of Biological Chemistry. 286(48). 41626–41635. 27 indexed citations

10.

Hoppman, Nicole L., John C. McLenithan, Daniel J. McBride, et al.. (2010). A common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitro. Bone. 47(2). 272–280. 7 indexed citations

11.

Shen, Haiqing, Toni I. Pollin, Coleen Damcott, et al.. (2009). Glucokinase regulatory protein gene polymorphism affects postprandial lipemic response in a dietary intervention study. Human Genetics. 126(4). 567–574. 20 indexed citations

12.

Pollin, Toni I., Coleen Damcott, Haiqing Shen, et al.. (2008). A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection. Science. 322(5908). 1702–1705. 517 indexed citations breakdown →

13.

Wang, Hong, Hui Chen, John C. McLenithan, et al.. (2008). Consequences of Lipid Droplet Coat Protein Downregulation in Liver Cells. Diabetes. 57(8). 2037–2045. 165 indexed citations

14.

Prior, Steven J., James M. Hagberg, Chad M. Paton, et al.. (2005). DNA sequence variation in the promoter region of theVEGFgene impactsVEGFgene expression and maximal oxygen consumption. American Journal of Physiology-Heart and Circulatory Physiology. 290(5). H1848–H1855. 87 indexed citations

15.

Yang, Rongze, Qing Huang, John C. McLenithan, et al.. (2003). Comparative studies of resistin expression and phylogenomics in human and mouse. Biochemical and Biophysical Research Communications. 310(3). 927–935. 174 indexed citations

16.

Hui, Hongxiang, Karim Chamie, Stefan Binder, et al.. (2001). Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. Journal of Molecular Endocrinology. 27(2). 133–144. 28 indexed citations

17.

Jiang, Man‐Shiow, Qi‐Qun Tang, John C. McLenithan, et al.. (1998). Derepression of the C/EBPα gene during adipogenesis: Identification of AP-2α as a repressor. Proceedings of the National Academy of Sciences. 95(7). 3467–3471. 76 indexed citations

18.

Whiteheart, Sidney W., John C. McLenithan, & Gerald W. Hart. (1990). Surfaces of murine lymphocyte subsets differ in sialylation states and antigen distribution of a major N-linked penultimate saccharide structure. Cellular Immunology. 125(2). 337–353. 25 indexed citations

19.

Aniya, Yoko, John C. McLenithan, & M.W. Anders. (1988). Isozyme selective arylation of cytosolic glutathione S-transferase by [14C]bromobenzene metabolites. Biochemical Pharmacology. 37(2). 251–257. 10 indexed citations

20.

McLenithan, John C., et al.. (1985). Purification and characterization of S-phenacylglutathione reductase from rat liver.. Journal of Biological Chemistry. 260(21). 11749–11754. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact